APA aipamena

Mohamed, A., Bennett, N., Ploetz, J., Aragon, L., Kennedy, K., & Boyd, S. E. (2020). 266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Open Forum Infect Dis.

Chicago Style aipamena

Mohamed, Adham, Nick Bennett, Jeannette Ploetz, Laura Aragon, Kevin Kennedy, and Sarah E. Boyd. "266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia." Open Forum Infect Dis 2020.

MLA aipamena

Mohamed, Adham, et al. "266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia." Open Forum Infect Dis 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.